Prevention of mother to child transmission of HIV: Our experience in South India
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To determine the outcomes of various ARV (Anti-Retroviral) prophylactic regimes given to HIV positive pregnant mothers, based on time of presentation, for prevention of vertical transmission.
During a four year period, 92 pregnant HIV positive women and their newborn infants received various ARV prophylactic regimes for prevention of vertical transmission. The outcome, in terms of presence of HIV infection in the infants born to these mothers was studied.
The prevalence of HIV infection in the antenatal group studied was 0.62%. Of the 92 HIV positive pregnant mothers who delivered live babies, 91.3% received ARV prophylaxis or HAART, and 95.6% of the 92 live infants received ARV prophylaxis. The risk of vertical transmission was only 3.3%.
Judicious PMTCT regimes, even if they appear complex, are possible in the Indian setting, and can result in significant decline of HIV positive children. Duration of treatment and mode of delivery should be based on the time of presentation of the HIV positive pregnant mother.
- Gupta A, Gupte N, Sastry J et al. Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India. Indian J Med Res 2007;126:131–134.
- Indian Council of Medical Research. National Institute of Medical Statistics. National AIDS Control Organisation. Technical report — India HIV estimates —2006. New Delhi, ICMR, 2006.
- Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173–1180. CrossRef
- Rongkavilit C, Asmar BI. Advances in prevention of mother-to-child HIV transmission. Indian J Pediatr 2004;71:69–79. CrossRef
- Lallemant M, Jourdain G, Le Coeur S et al. A trial of shortened zidovudine regimens to prevent mother-tochild transmission of human immunodeficiency virus type 1. N Engl J Med 2000;343:982–991. CrossRef
- Shaffer N, Chuachoowong R, Mock PA et al. Shortcourse zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353:773–780. CrossRef
- Lallemant M, Jourdain G, Le Coeur S et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004;351:217–228. CrossRef
- Dongoankar D, Taykar AV, Subash AA et al. Perinatal transmission of HIV infection in Mumbai, India. J Obstet Gynaecol India 2001;51:56–60
- Dongoankar D. Prevention of mother to child transmission of HIV-1 using anti-retroviral drug — Zidovudine. J Obstet Gynaecol India 2003;53:563–567.
- Prevention of mother to child transmission of HIV: Our experience in South India
The Journal of Obstetrics and Gynecology of India
Volume 61, Issue 1 , pp 62-66
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- mother-to-child transmission
- vertical transmission
- ARV prophylaxis